Jeremy Parsons, M.D.
Clinical Pathology/Laboratory Medicine Physician in Albuquerque, New Mexico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,229 in Clinical Pathology/Laboratory Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Jeremy Parsons, M.D. reported a CMS MIPS final score of 83.8/100 - above the 83.5 national average - and filed 29 Medicare Part D claims in 2023.
- 83.8/100
- MIPS score · +0 vs avg
- 29
- Part D claims, 2023
- 38%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Jeremy Parsons, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1427254572), first enumerated 06/25/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 29 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 83.8/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$29.38 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1427254572 · Clinical Pathology/Laboratory Medicine Physician
NPI-10 · ENUM-MID · TAX-NARROW · MIPS-INLINE · RX-TRACE · BOOK-THIN · PHOTO-FINISH
- NPI-10 1427254572
- ENUM-MID 2007
- TAX-NARROW 1,229
- MIPS-INLINE 83.8/100
- RX-TRACE 29
- BOOK-THIN 23 in New Mexico
- PHOTO-FINISH Rex Burrow · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Parsons · this p…
Parsons · this provider
83.8 MIPS pts
- Rex Burrow · near
Rex Burrow
83.8 MIPS pts
- Britni Bryant · …
Britni Bryant
83.9 MIPS pts
- Nada Naiyer · near
Nada Naiyer
83.9 MIPS pts
- Mark Rodacker · …
Mark Rodacker
84 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Jeremy Parsons, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
84 ≥ 39th percentile 39% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Jeremy Parsons, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jeremy Parsons, M.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Mexico
How Clinical Pathology/Laboratory Medicine Physician compares to other specialties among New Mexico providers
Clinical Pathology/Laboratory Medicine Physician ranks #139 among New Mexico's specialties (0% of in-state providers)
Each bar is a specialty's share of the New Mexico provider total, by primary NUCC taxonomy. The highlighted bar is Clinical Pathology/Laboratory Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Jeremy Parsons, M.D.'s 2023 MIPS final score plotted against the Clinical Pathology/Laboratory Medicine Physician national average
- MIPS Final Score
- 83.8/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Clinical Pathology/Laboratory Medicine Physician US NPIs
83.8/100 MIPS final score - 0.3 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Clinical Pathology/Laboratory Medicine Physician. Quality dim: 84.6. Cost dim: 58.6.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1427254572 |
|---|---|
| Specialty | Clinical Pathology/Laboratory Medicine Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/25/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Jeremy Parsons, M.D.'s current license status, disciplinary history, and board certifications with the New Mexico Medical Board in New Mexico before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1427254572 is the unique 10-digit identifier CMS uses to link Parsons across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Jeremy Parsons, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jeremy Parsons, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$29
Largest payer
JAZZ PHARMACEUTICALS INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
62% brand-name claims vs 38% generic, on 29 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 40
- Total Day Supply
- 1,216
- Brand vs Generic
- 62% brand / 38% generic
- Brand Drug Cost
- $14K
- Generic Drug Cost
- $236
Patient Demographics
- Average Patient Age
- 65.9 years
- Avg HCC Risk Score
- 1.21
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Xarelto Rivaroxaban | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Clinical Pathology/Laboratory Medicine Physician Overview
How Jeremy Parsons, M.D. fits within the Clinical Pathology/Laboratory Medicine Physician landscape nationally.
Jeremy Parsons, M.D.'s 29 claims are below the specialty average of 149.
Nationwide Clinical Pathology/Laboratory Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Parsons, both outside New Mexico so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (83.8 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Clinical Pathology/Laboratory Medicine Physician Providers in New Mexico
Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as Parsons.
One of 23 Clinical Pathology/Laboratory Medicine Physician providers enrolled in New Mexico, 5 are shown here.
Frequently Asked Questions
What is Jeremy Parsons, M.D.'s specialty? ▼
How much does Jeremy Parsons, M.D. prescribe under Medicare Part D? ▼
What is Jeremy Parsons, M.D.'s Medicare quality score? ▼
Where is Jeremy Parsons, M.D. located? ▼
What is Jeremy Parsons, M.D.'s NPI number? ▼
Does Jeremy Parsons, M.D. prescribe more brand-name or generic drugs? ▼
How many Clinical Pathology/Laboratory Medicine Physician providers are there in the US? ▼
What drugs does Jeremy Parsons, M.D. prescribe most often? ▼
Does Jeremy Parsons, M.D. accept Medicare? ▼
How can I verify Jeremy Parsons, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.